XML 59 R49.htm IDEA: XBRL DOCUMENT v3.19.1
Identifiable Intangible Assets - Additional Information (Detail) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]      
Amortization of intangible assets useful life     12 years
Amortization of intangible assets $ 283 $ 310  
IPR&D to product rights 236    
Impairment of intangible assets excluding goodwill 469 $ 206  
Methyl ER [Member]      
Finite-Lived Intangible Assets [Line Items]      
IPR&D to product rights 174    
Lenalidomide Product [Member]      
Finite-Lived Intangible Assets [Line Items]      
Impairment of intangible assets excluding goodwill 125    
In Process Research and Development [Member]      
Finite-Lived Intangible Assets [Line Items]      
Impairment of intangible assets excluding goodwill 265    
Actavis [Member]      
Finite-Lived Intangible Assets [Line Items]      
Impairment of intangible assets excluding goodwill 140    
Actavis [Member] | In Process Research and Development [Member]      
Finite-Lived Intangible Assets [Line Items]      
Business combination recognized identifiable assets 1,935    
Actavis [Member] | Identifiable product rights [Member]      
Finite-Lived Intangible Assets [Line Items]      
Impairment of intangible assets excluding goodwill 204    
Rimsa [Member] | In Process Research and Development [Member]      
Finite-Lived Intangible Assets [Line Items]      
Business combination recognized identifiable assets 47    
AUSTEDO [Member] | In Process Research and Development [Member]      
Finite-Lived Intangible Assets [Line Items]      
Business combination recognized identifiable assets $ 211